The prognostic significance of different clinical, radiological and laboratory parameters in sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 46s Year: 2003
The clinical value of bodybox measurements Source: International Congress 2015 – CC5 Interpretation of pulmonary function testing Year: 2015
The best cut-off value in predicting intensive care in the rapid response system: The preliminary study Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021
What requirements should a biomarker meet to be used in the clinical and epidemiological setting? Source: Annual Congress 2008 - Biomarkers in COPD - application in clinical and epidemiological studies Year: 2008
A simple algorithm for the identification of clinical COPD phenotypes Source: Eur Respir J, 50 (5) 1701034; 10.1183/13993003.01034-2017 Year: 2017
A basic prediction model with clinical parameters to diagnose lung cancer. Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer Year: 2021
The prognostic value of some clinical and laboratory parameters in sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 434s Year: 2002
Comparison of morphological and densitometric indicators of the inflammatory process activity for substantiation of the optimal terms of surgical treatment in patients with various forms of TB Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes Year: 2020
Applications of clinical exercise testing: different formats, different prognostic outcomes Source: Annual Congress 2013 –PG14 Cardiopulmonary exercise testing in the evaluation of patients with respiratory diseases Year: 2013
Applications of clinical exercise testing: different formats, different prognostic outcomes Source: International Congress 2014 – PG07 Cardiopulmonary exercise testing Year: 2014
A critical evaluation of the relevance of different asthma phenotypes for clinical practice Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008
Workstation 3 - Spirometry - how to perform a spirometic test, implementing safety measures, selecting the best values and simulating errors Source: Annual Congress 2013 –Educational skills workshop 7: Spirometry knowledge and basic skills (European spirometry training programme) Year: 2013
Evaluation of factors to consider prior to adjustment of biologic quality control ranges using data from a large multi-centre clinical trial Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009
Do the current endpoints in IPF clinical trials allow good regulatory decisions to be made? Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases" Year: 2014
Evaluation of a method for establishing biologic quality control ranges from the first 20 acceptable test sessions in a large multi-center study Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009
Workstation 2 – Spirometry: performing the test, safety measures, selecting the best values and simulating errors Source: International Congress 2014 – EW9 Spirometry knowledge and basic skills (European spirometry training programme) Year: 2014
Workstation 2 – Spirometry: performing the test, safety measures, selecting the best values and simulating errors Source: International Congress 2014 – EW8 Spirometry knowledge and basic skills (European spirometry training programme) Year: 2014
The clinical value of trend reports in pulmonary function testing Source: International Congress 2015 – CC5 Interpretation of pulmonary function testing Year: 2015
Is pathological response a valid surrogate for outcome? Source: Virtual Congress 2021 – Hot topics in thoracic oncology Year: 2021
Overall clinical approach Source: Virtual Congress 2021 – ERS Clinical practice guidelines for managing children and adolescents with bronchiectasis Year: 2021